The Analysis Of Final And Surrogate Effectiveness Criteria Used In Health Economic Studies Of Drugs Submitted Into The Reimbursement In Russia In 2016
Abstract
Authors
A Kolbin VV Omelianovskiy A Kurylev
A Kolbin VV Omelianovskiy A Kurylev
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now